Dr Angeliki Kazeros, MD | |
415 E 37th St, Apt 11c, New York, NY 10016-3200 | |
(212) 532-2951 | |
Not Available |
Full Name | Dr Angeliki Kazeros |
---|---|
Gender | Female |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 415 E 37th St, New York, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003089442 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 235363-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Angeliki Kazeros, MD 415 E 37th St, Apt 11c, New York, NY 10016-3200 Ph: (212) 532-2951 | Dr Angeliki Kazeros, MD 415 E 37th St, Apt 11c, New York, NY 10016-3200 Ph: (212) 532-2951 |
News Archive
Comprehensive Health Services, Inc. (CHS), a leading national workforce health management company specializing in onsite health care solutions, received a coveted accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC) for two of its new HybridHealthSM onsite health centers. In just thirteen months from the completion of construction to their accreditation, the Choose Health Wellness Center at Hewitt Associates in Lincolnshire, Illinois, as well as an onsite health center at a company in Texas, accomplished top ratings in all AAAHC's core standards.
Clocking up just a few minutes at a time of any level of physical activity, including of light intensity, is linked to a lower risk of death in older men, suggests research published online in the British Journal of Sports Medicine.
Under an $11-million grant from the National Institutes of Health (NIH), Dartmouth Medical School (DMS) will lead a network of northern New England institutions in recruiting, training, and supporting young quantitative biologists to teach and conduct research into the ways that genes and the environment work together to trigger and prevent disease.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
› Verified 7 days ago
Dr. Ravishankar Ramaswamy, MD, MS Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |